These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 9416651)

  • 1. Validity of specific subscales of the positive and negative symptom scales in older schizophrenia outpatients.
    McAdams LA; Harris MJ; Heaton SC; Bailey A; Fell R; Jeste DV
    Schizophr Res; 1997 Oct; 27(2-3):219-26. PubMed ID: 9416651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validating specific psychopathology scales in older outpatients with schizophrenia.
    McAdams LA; Harris MJ; Bailey A; Fell R; Jeste DV
    J Nerv Ment Dis; 1996 Apr; 184(4):246-51. PubMed ID: 8604035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Core factors of schizophrenia structure based on PANSS and SAPS/SANS results. Discerning and head-to-head comparisson of PANSS and SASPS/SANS validity].
    Masiak M; Loza B
    Psychiatr Pol; 2004; 38(5):795-808. PubMed ID: 15523927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of positive and negative symptoms in schizophrenia.
    Malla AK; Norman RM; Williamson P
    Can J Psychiatry; 1993 Nov; 38(9):617-21. PubMed ID: 8306235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sensitivity of quality-of-life scale WHOQOL-100 to psychopathological measures in schizophrenia.
    Orsel S; Akdemir A; Dağ I
    Compr Psychiatry; 2004; 45(1):57-61. PubMed ID: 14671738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variability in BPRS definitions of positive and negative symptoms.
    Nicholson IR; Chapman JE; Neufeld RW
    Schizophr Res; 1995 Oct; 17(2):177-85. PubMed ID: 8562492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of positive and negative symptom constructs during neuroleptic treatment in schizophrenia.
    Goldman RS; Tandon R; Liberzon I; Goodson J; Greden JF
    Psychopathology; 1991; 24(4):247-52. PubMed ID: 1754657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative symptoms in schizophrenia: their evolution during an acute phase.
    Dollfus S; Petit M
    Schizophr Res; 1995 Oct; 17(2):187-94. PubMed ID: 8562493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multisite investigation of the reliability of the Scale for the Assessment of Negative Symptoms.
    Mueser KT; Sayers SL; Schooler NR; Mance RM; Haas GL
    Am J Psychiatry; 1994 Oct; 151(10):1453-62. PubMed ID: 7916540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing negative symptoms in schizophrenia: Validity of the clinical assessment interview for negative symptoms in Singapore.
    Rekhi G; Ang MS; Yuen CKY; Ng WY; Lee J
    Schizophr Res; 2019 Apr; 206():177-182. PubMed ID: 30558979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptom assessment in early psychosis: the use of well-established rating scales in clinical high-risk and recent-onset populations.
    Fulford D; Pearson R; Stuart BK; Fisher M; Mathalon DH; Vinogradov S; Loewy RL
    Psychiatry Res; 2014 Dec; 220(3):1077-83. PubMed ID: 25278477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of negative symptoms and depression in schizophrenia: revision of the SANS and how it relates to the PANSS and CDSS.
    Rabany L; Weiser M; Werbeloff N; Levkovitz Y
    Schizophr Res; 2011 Mar; 126(1-3):226-30. PubMed ID: 21115328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Converting positive and negative symptom scores between PANSS and SAPS/SANS.
    van Erp TG; Preda A; Nguyen D; Faziola L; Turner J; Bustillo J; Belger A; Lim KO; McEwen S; Voyvodic J; Mathalon DH; Ford J; Potkin SG; Fbirn
    Schizophr Res; 2014 Jan; 152(1):289-94. PubMed ID: 24332632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hopelessness in schizophrenia: the impact of symptoms and beliefs about illness.
    White RG; McCleery M; Gumley AI; Mulholland C
    J Nerv Ment Dis; 2007 Dec; 195(12):968-75. PubMed ID: 18091189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of depression and negative symptoms in schizophrenia.
    Goldman RS; Tandon R; Liberzon I; Greden JF
    Psychopathology; 1992; 25(1):49-56. PubMed ID: 1351305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptom structure in schizophrenia: two-, three- or four-factor models?
    Dollfus S; Everitt B
    Psychopathology; 1998; 31(3):120-30. PubMed ID: 9636941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic validity of assessment scales for depression in patients with schizophrenia.
    Kim SW; Kim SJ; Yoon BH; Kim JM; Shin IS; Hwang MY; Yoon JS
    Psychiatry Res; 2006 Sep; 144(1):57-63. PubMed ID: 16904189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does catatonia influence the phenomenology of childhood onset schizophrenia beyond motor symptoms?
    Bonnot O; Tanguy ML; Consoli A; Cornic F; Graindorge C; Laurent C; Tordjman S; Cohen D
    Psychiatry Res; 2008 Apr; 158(3):356-62. PubMed ID: 18272234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Self-rating scales in schizophrenia: validity assessment of the Paranoid-Depression Scale (PD-S), the Frankfurt Self-feeling Scale (FBS) and of two visual analogy scales].
    Schaeffer E; Wciórka J
    Psychiatr Pol; 2003; 37(2):293-314. PubMed ID: 12776660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of positive and negative symptoms in schizophrenia. A study from a population of long-term outpatients.
    Palacios-Araus L; Herrán A; Sandoya M; González de la Huebra E; Vázquez-Barquero JL; Díez-Manrique JF
    Acta Psychiatr Scand; 1995 Sep; 92(3):178-82. PubMed ID: 7484194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.